Literature DB >> 25546742

Common variable immunodeficiency (CVID): new genetic insight and unanswered questions.

H D Ochs1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25546742      PMCID： PMC4285471          DOI： 10.1111/cei.12491

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  12 in total

1.  Is there a need to redefine the diagnostic criteria for common variable immunodeficiency?

Authors:  Mikko Seppänen; Asghar Aghamohammadi; Nima Rezaei
Journal:  Expert Rev Clin Immunol       Date:  2013-12-10       Impact factor: 4.473

Review 2.  The variable in common variable immunodeficiency: a disease of complex phenotypes.

Authors:  Stephen Jolles
Journal:  J Allergy Clin Immunol Pract       Date:  2013-10-31

3.  Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID).

Authors:  Nicole M Chase; James W Verbsky; Mary K Hintermeyer; Jill K Waukau; Aoy Tomita-Mitchell; James T Casper; Sumit Singh; Kaushik S Shahir; William B Tisol; Melodee L Nugent; R Nagarjun Rao; A Craig Mackinnon; Lawrence R Goodman; Pippa M Simpson; John M Routes
Journal:  J Clin Immunol       Date:  2012-08-29       Impact factor: 8.317

4.  Morbidity and mortality in common variable immune deficiency over 4 decades.

Authors:  Elena S Resnick; Erin L Moshier; James H Godbold; Charlotte Cunningham-Rundles
Journal:  Blood       Date:  2011-12-16       Impact factor: 22.113

5.  A recurrent dominant negative E47 mutation causes agammaglobulinemia and BCR(-) B cells.

Authors:  Bertrand Boisson; Yong-Dong Wang; Amma Bosompem; Cindy S Ma; Annick Lim; Tatiana Kochetkov; Stuart G Tangye; Jean-Laurent Casanova; Mary Ellen Conley
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

6.  Germline mutations in NFKB2 implicate the noncanonical NF-κB pathway in the pathogenesis of common variable immunodeficiency.

Authors:  Karin Chen; Emily M Coonrod; Attila Kumánovics; Zechariah F Franks; Jacob D Durtschi; Rebecca L Margraf; Wilfred Wu; Nahla M Heikal; Nancy H Augustine; Perry G Ridge; Harry R Hill; Lynn B Jorde; Andrew S Weyrich; Guy A Zimmerman; Adi V Gundlapalli; John F Bohnsack; Karl V Voelkerding
Journal:  Am J Hum Genet       Date:  2013-10-17       Impact factor: 11.025

7.  Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency.

Authors:  Carrie L Lucas; Hye Sun Kuehn; Fang Zhao; Julie E Niemela; Elissa K Deenick; Umaimainthan Palendira; Danielle T Avery; Leen Moens; Jennifer L Cannons; Matthew Biancalana; Jennifer Stoddard; Weiming Ouyang; David M Frucht; V Koneti Rao; T Prescott Atkinson; Anahita Agharahimi; Ashleigh A Hussey; Les R Folio; Kenneth N Olivier; Thomas A Fleisher; Stefania Pittaluga; Steven M Holland; Jeffrey I Cohen; Joao B Oliveira; Stuart G Tangye; Pamela L Schwartzberg; Michael J Lenardo; Gulbu Uzel
Journal:  Nat Immunol       Date:  2013-10-28       Impact factor: 25.606

8.  Agammaglobulinemia and absent B lineage cells in a patient lacking the p85α subunit of PI3K.

Authors:  Mary Ellen Conley; A Kerry Dobbs; Anita M Quintana; Amma Bosompem; Yong-Dong Wang; Elaine Coustan-Smith; Amber M Smith; Elena E Perez; Peter J Murray
Journal:  J Exp Med       Date:  2012-02-20       Impact factor: 14.307

9.  Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity.

Authors:  Gabriela Lopez-Herrera; Giacomo Tampella; Qiang Pan-Hammarström; Peer Herholz; Claudia M Trujillo-Vargas; Kanchan Phadwal; Anna Katharina Simon; Michel Moutschen; Amos Etzioni; Adi Mory; Izhak Srugo; Doron Melamed; Kjell Hultenby; Chonghai Liu; Manuela Baronio; Massimiliano Vitali; Pierre Philippet; Vinciane Dideberg; Asghar Aghamohammadi; Nima Rezaei; Victoria Enright; Likun Du; Ulrich Salzer; Hermann Eibel; Dietmar Pfeifer; Hendrik Veelken; Hans Stauss; Vassilios Lougaris; Alessandro Plebani; E Michael Gertz; Alejandro A Schäffer; Lennart Hammarström; Bodo Grimbacher
Journal:  Am J Hum Genet       Date:  2012-05-17       Impact factor: 11.025

Review 10.  Common variable immunodeficiency: an update.

Authors:  Ulrich Salzer; Klaus Warnatz; Hans Hartmut Peter
Journal:  Arthritis Res Ther       Date:  2012-09-24       Impact factor: 5.156
View more
  6 in total

Review 1.  Flow Cytometry, a Versatile Tool for Diagnosis and Monitoring of Primary Immunodeficiencies.

Authors:  Roshini S Abraham; Geraldine Aubert
Journal:  Clin Vaccine Immunol       Date:  2016-04-04

Review 2.  Common Variable Immunodeficiency and Liver Involvement.

Authors:  Junmin Song; Ana Lleo; Guo Xiang Yang; Weici Zhang; Christopher L Bowlus; M Eric Gershwin; Patrick S C Leung
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

Review 3.  Epigenetic control of the immune system: a lesson from Kabuki syndrome.

Authors:  Stefano Stagi; Anna Virginia Gulino; Elisabetta Lapi; Donato Rigante
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

4.  Low Circulating Natural Killer Cell Counts are Associated With Severe Disease in Patients With Common Variable Immunodeficiency.

Authors:  Mikael Ebbo; Laurence Gérard; Sabrina Carpentier; Frédéric Vély; Sophie Cypowyj; Catherine Farnarier; Nicolas Vince; Marion Malphettes; Claire Fieschi; Eric Oksenhendler; Nicolas Schleinitz; Eric Vivier
Journal:  EBioMedicine       Date:  2016-03-02       Impact factor: 8.143

5.  Genomic crossroads between non-Hodgkin's lymphoma and common variable immunodeficiency.

Authors:  Kissy Guevara-Hoyer; Jesús Fuentes-Antrás; Eduardo de la Fuente-Muñoz; Miguel Fernández-Arquero; Fernando Solano; Pedro Pérez-Segura; Esmeralda Neves; Alberto Ocaña; Rebeca Pérez de Diego; Silvia Sánchez-Ramón
Journal:  Front Immunol       Date:  2022-08-05       Impact factor: 8.786

6.  Common variable immunodeficiency and natural killer cell lymphopenia caused by Ets-binding site mutation in the IL-2 receptor γ (IL2RG) gene promoter.

Authors:  Anita Chandra; Fang Zhang; Kimberly C Gilmour; David Webster; Vincent Plagnol; Dinakantha S Kumararatne; Siobhan O Burns; Sergey Nejentsev; Adrian J Thrasher
Journal:  J Allergy Clin Immunol       Date:  2015-10-31       Impact factor: 10.793
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.